Vanja Douglas, MD


Dr. Vanja Douglas is a neurohospitalist who specializes in managing the care of patients with neurological diseases while in the hospital. His expertise includes stroke, Guillain-Barre syndrome, multiple sclerosis, seizures, meningitis and delirium as well as less common conditions such as acute transverse myelitis, refractory status epilepticus, infectious encephalitis and autoimmune encephalitis.

Douglas earned a medical degree at the UCSF School of Medicine and completed an internship in internal medicine and residency in neurology, serving as chief resident, at UCSF. He also completed a neurohospitalist fellowship at UCSF. In July 2009, Douglas joined the UCSF faculty as an associate clinical professor in the neurohospitalist program. He is board certified by the American Board of Psychiatry and Neurology.

More about Vanja Douglas

Additional Languages



UCSF School of Medicine 2004


UCSF Medical Center 2008


UCSF, Neurohospitalist Medicine 2009

Selected Research and Publications

  1. Hargrave A, Bastiaens J, Bourgeois JA, Neuhaus J, Josephson SA, Chinn J, Lee M, Leung J, Douglas V. Validation of a Nurse-Based Delirium-Screening Tool for Hospitalized Patients. Psychosomatics. 2017 Jul 24.
  2. Brown EG, Josephson SA, Anderson N, Reid M, Lee M, Douglas VC. Predicting inpatient delirium: The AWOL delirium risk-stratification score in clinical practice. Geriatr Nurs. 2017 May 19.
  3. Langelier C, Reid MJ, Halabi C, Witek N, LaRiviere A, Shah M, Wilson MR, Chin-Hong P, Douglas V, Kazacos KR, Babik JM. Baylisascaris procyonis-Associated Meningoencephalitis in a Previously Healthy Adult, California, USA. Emerg Infect Dis. 2016 08; 22(8):1480-4.
  4. Robbins NM, Shah V, Benedetti N, Talbott JF, Chin CT, Douglas VC. Magnetic resonance neurography in the diagnosis of neuropathies of the lumbosacral plexus: a pictorial review. Clin Imaging. 2016 Nov - Dec; 40(6):1118-1130.
  5. Guterman EL, Douglas VC, Shah MP, Parsons T, Barba J, Josephson SA. National characteristics and predictors of neurologic 30-day readmissions. Neurology. 2016 Feb 16; 86(7):669-75.
  6. Shah M, Douglas V, Scott B, Josephson SA. A Neurohospitalist Discharge Clinic Shortens the Transition From Inpatient to Outpatient Care. Neurohospitalist. 2016 Apr; 6(2):64-9.
  7. Josephson SA, Douglas VC. Hospitalist Neurology. Semin Neurol. 2015 Dec; 35(6):609.
  8. Brown EG, Douglas VC. Moving Beyond Metabolic Encephalopathy: An Update on Delirium Prevention, Workup, and Management. Semin Neurol. 2015 Dec; 35(6):646-55.
  9. Pastula DM, Burish M, Reis GF, Bollen A, Cha S, Ralph J, Douglas VC. Adult-onset central nervous system hemophagocytic lymphohistiocytosis: a case report. BMC Neurol. 2015 Oct 14; 15:203.
  10. Zeng L, Josephson SA, Fukuda KA, Neuhaus J, Douglas VC. A Prospective Comparison of Informant-based and Performance-based Dementia Screening Tools to Predict In-Hospital Delirium. Alzheimer Dis Assoc Disord. 2015 Oct-Dec; 29(4):312-6.
  11. Douglas V, Shamy M, Bhattacharya P. Should CT Angiography be a Routine Component of Acute Stroke Imaging? Neurohospitalist. 2015 Jul; 5(3):97-8.
  12. Horton JC, Douglas VC, Cha S. Reduced apparent diffusion coefficient in neuromyelitis optica-associated optic neuropathy. J Neuroophthalmol. 2015 Mar; 35(1):101-2.
  13. Chiovaro J, Douglas V, Gaggar A, Dhaliwal G. Exhausting the differential. J Gen Intern Med. 2014 May; 29(5):808-12.
  14. Kamel H, Betjemann JP, Navi BB, Hegde M, Meisel K, Douglas VC, Josephson SA. Diagnostic yield of electroencephalography in the medical and surgical intensive care unit. Neurocrit Care. 2013 Dec; 19(3):336-41.
  15. Betjemann JP, Nguyen I, Santos-Sanchez C, Douglas VC, Josephson SA. Diagnostic yield of electroencephalography in a general inpatient population. Neurodiagn J. 2013 Sep; 53(3):207-16.
  16. Douglas VC, Hessler CS, Dhaliwal G, Betjemann JP, Fukuda KA, Alameddine LR, Lucatorto R, Johnston SC, Josephson SA. The AWOL tool: derivation and validation of a delirium prediction rule. J Hosp Med. 2013 Sep; 8(9):493-9.
  17. Rubenstein JL, Wong VS, Kadoch C, Gao HX, Barajas R, Chen L, Josephson SA, Scott B, Douglas V, Maiti M, Kaplan LD, Treseler PA, Cha S, Hwang JH, Cinque P, Cyster JG, Lowell C. CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma. Blood. 2013 Jun 06; 121(23):4740-8.
  18. Betjemann JP, Nguyen I, Santos-Sanchez C, Douglas VC, Josephson SA. Diagnostic yield of electroencephalography in a general inpatient population. Mayo Clin Proc. 2013 Apr; 88(4):326-31.
  19. Scott BJ, Douglas VC, Tihan T, Rubenstein JL, Josephson SA. A systematic approach to the diagnosis of suspected central nervous system lymphoma. JAMA Neurol. 2013 Mar 01; 70(3):311-9.
  20. Cassese T, Kaplan E, Douglas V, Dhaliwal G. Getting to the right question. J Gen Intern Med. 2013 Sep; 28(9):1242-6.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.